BRADLEY OPHOFF: Open Payments
NPI 1275142986 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 13 payments from 9 companies in 2025. Trend: 2023 $105 · 2024 $112 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 3 | $177 |
| Medtronic, Inc. | 1 | $165 |
| Amgen Inc. | 2 | $150 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| GENZYME CORPORATION | 1 | $23 |
| Greer Laboratories, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: NEFFY, PROPEL, TEPEZZA, AIRSUPRA, DUPIXENT, ORALAIR, NUCALA, EOHILIA.
Industry payments across IN — which companies pay providers there.
